What type of Cancer is
XyChloro Photodynamic Therapy (XPDT)
most effective on?

A pre-condition for a successful treatment is that the patient should be in reasonably good health. Also, the cancer should not yet have seriously damaged vital structures and organs. It is important not to leave it too late before seeking out this therapy.

XyChloro Photodynamic Therapy (XPDT) has a slow tumor killing effect (surgery is fast), and we can expect it to work best when there is not much cancer present, or when the cancer consist of a large number of small tumors rather than as a small number of large tumors. XyChloro Photodynamic Therapy (XPDT) is not as effective with large, dense tumors, probably because blood circulation inside the tumor is poor, and it is difficult to get the sensitizer into the deep cancer cells. Fortunately, these tumors can usually be removed or at lease debulked surgically.

When the patient has a lot of cancer, expect (XPDT) to do best when:
a. The cancer is on or near the surface, where (XPDT) are very effective, although our new deeper penetrating light delivery system is much better at reaching further into the body, and
b. When we can easily monitor the progress of the therapy using Photodynamic Diagnostic (PDD). (PDD) is an advanced monitoring technique that allows us to see cancer cells and determine when our treatment is being successful. When applicable, it is very efficient and sensitive.

The top two cancers for XyChloro Photodynamic Therapy (XPDT) are BREAST AND SKIN CANCER, because both can be monitored using Photodynamic Diagnostic (PDD). PROSTATE CANCER is a close third. Here, progress can be monitored on a day by day basis by observing changes in symptoms and by digital rectal examination by sonography and darkfield microscopy.

We have had a number of successes using XyChloro Photodynamic Therapy (XPDT) with other cancers, but our performance with deeper cancers has been less consistent.

XyChloro Photodynamic Therapy (XPDT) is not very dependant on knowledge of the type of cancer. It does not appear to make much difference to the outcome. What our doctors do need to know is the size and location of the primary tumor, and has a general indication where metastases may be. It is also necessary to know if the cancer has affected vital structures, making it unsafe to kill the cancer and leave a dangerous "hole".

Conventional therapies need to know the above and a lot more. Chemotherapy and hormone therapy are dependant on an accurate diagnosis of the type of cancer. For example, oestrogen dependant breast cancers may respond to hormone therapy, others will not. It is sometimes difficult to determine the type of cancer present, and a misdiagnosis may result in the patient getting treatment, which cannot possibly be effective. Radiation therapy and surgery are both dependant on an accurate knowledge of where the tumor and its metastases are located. The XYTOS Cancer Treatment is effective without these specifics.